MedTrace Logo

Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial

NCT05356117 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2026-02-19

No results posted yet for this study

Summary

The purpose of this research is to determine whether a virtually supervised resistance exercise (RE) intervention combined with protein supplementation (PS) is feasible in pancreatic cancer patients initiating chemotherapy and if it will improve skeletal muscle mass.

The names of the study interventions involved in this study are:

* Resistance training and protein supplement intake (RE + PS)
* Resistance training (RE)
* Attention control (AC), home-based stretching

Conditions

Interventions

BEHAVIORAL

Resistance Training (RT) and Protein Supplementation (PS)

Aerobic and resistance exercise with orally consumed pre-packed protein supplement

BEHAVIORAL

Resistance Training (RT)

Aerobic and resistance exercise

BEHAVIORAL

Attention Control (AC

Stretching

Sponsors & Collaborators

Principal Investigators

  • Christina M Dieli-Conwright, PhD, MPH · Dana-Farber Cancer Institute

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2027-01-31
Completion
2027-08-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05356117 on ClinicalTrials.gov